Islamabad, Nov 11 : Pakistan Tehrik-e-
Islamabad, Nov 11 : President Pervez Musharraf has amended the ArmMotilal Oswal Financial Services has reiterated a BUY rating on Kalyan Jewellers, maintaining a target price of Rs700 — an 18% upside from the current market price of Rs591.
News in Focus
Featured, Company Results, Analyst View, Futures & Options, Bullion Update, India, Kalyan Jewellers, Motilal Oswal
Motilal Oswal Financial Services has reiterated a BUY rating on Nuvama Wealth, raising its target price to Rs2,100 — a 16% upside from the current market price of Rs1,804.
Godrej Properties Share Price Could Reach Rs 2,350: Motilal Oswal Financial Services Remains Bullish
Featured, India Business, Analyst View, Stock Markets, Godrej Properties, India, Motilal Oswal, Real Estate
Godrej Properties Ltd reported a 22% year-on-year rise in pre-sales to Rs 86.5 billion in the first quarter of FY27, an 8% beat on brokerage estimates, driven by strong launches across Bengaluru, t
Motilal Oswal Financial Services has retained its BUY rating on DLF Limited, setting a target price of Rs755, implying a 17% upside from the current market price of Rs643.
Motilal Oswal has reiterated a BUY rating on Blue Dart Express with a target price of Rs 6,100, implying 15% upside from the current market price of Rs 5,284.
Maharashtra has become the first Indian state to formally outlaw analogue paneer, a non-dairy imitation product linked to health complaints, in a sweeping one-year ban announced by Food and Drugs A
Main Regional Stories
Artificial intelligence is systematically reshaping the labor market, but not uniformly.
Featured, India Business, Analyst View, Stock Markets, Cummins India Ltd, Engineering Sector, India, Motilal Oswal
Motilal Oswal Financial Services has reiterated a Buy rating on Cummins India, trimming its target price slightly to Rs 6,500 from Rs 6,600, still implying 20% upside from the current market price of Rs 5,402.
Motilal Oswal Financial Services has reiterated a Buy rating on Godrej Agrovet, holding its target price at Rs 675, implying 24% upside from the current market price of Rs 545.
Featured, India Business, Analyst View, Stock Markets, Biocon, India, Motilal Oswal, Pharmaceutical Sector
Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact. Overall market sentiment is positive for pharmaceutical sector.
